Clinical Trial Update: The Effect Of Aspirin On Survival in Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aspirin's effect on survival in non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust | Conditions: Non Small Cell Lung Cancer, Survival | Phase 3 | Status: WITHDRAWN